Rare diseases specialist Swedish Orphan Biovitrum has appointed Anne Marie de Jonge Schuermans as head of its new Technical Operations organization, bringing together Sobi’s manufacturing operations/biological development and supply, quality, supply chain, procurement and environment and safety operations. 22 August 2018
UK biopharma firm PureTech Health has announced the appointment of Dr Steven Paul, as chief executive of its affiliate, Karuna Pharmaceuticals. 15 August 2018
Following the resignation of Dr Andrew Cheng, chief medical officer of US biotech major Gilead Sciences, the company has announced two promotions. 15 August 2018
Namir Hassan has been named chief scientific officer of Zelluna Immunotherapy, a privately-held Norwegian biotech specializing in T-cell receptor (TCR) immunotherapies. 13 August 2018
CAR-T therapy company Cellectis announced on Friday that Stefan Scherer, vice president and global lead for early development and innovation at Novartis, would join the company in a leadership role. 3 August 2018
Privately-owned UK biotech Cell Medica has named Chris Nowers its new chief executive after its founder and former leader Gregg Sando stepped down. 1 August 2018
In the 1980s, technologies such as DNA editing started to mature, creating a range of sophisticated and transformative therapeutic techniques - and a race to secure funding, technologies and expertise. 27 July 2018
Along with announcing analysts’ expectation-beating financials, leading biotech firm Amgen's outlined planned executive succession to address upcoming departures of two executive vice presidents. 27 July 2018
As was widely expected, US biotech Gilead Sciences late yesterday posted another quarter of falling sales and profits, but surprised with the announcement that both its chief executive and chairman were departing from the company. 26 July 2018
OncoSec Medical, a company developing intratumoral cancer immunotherapies, today announced the appointment of Sara Bonstein as Chief Financial Officer and Chief Operating Officer. 16 July 2018
USA-based biotech CytoDyn says it has signed a non-binding letter of intent regarding a proposed acquisition of intellectual property and other assets of ProstaGene. 16 July 2018
Chugai Pharma Europe, a wholly-owned subsidiary of Chugai Pharmaceutical and its majority owner Roche, has announced the hiring of Troy Robinson as managing director of its UK operations. 3 July 2018
Tilos Therapeutics, a biotech firm developing anti-LAP antibodies for the treatment of cancer, fibrosis and autoimmune diseases, today announced the appointment of Jessie English as chief scientific officer. 27 June 2018
China’s Zai Lab, a Shanghai-based innovative biopharmaceutical company, has appointed that William Liang as chief commercial officer, reporting to Dr Samantha Du, Zai Lab’s chief executive. 11 June 2018
Privately-held UK biotech Curve Therapeutics today announced the further strengthening of its leadership team with the appointments of Andre Hoekema as chairman of the board and Cora Griffin as head of business development. 2 October 2024
NK:IO, a London startup developing a cell therapy for treating solid tumors, has announced the appointment of a permant chief executive and the finalization of a seed funding round. 2 October 2024
Halda Therapeutics, a US biotech company advancing cancer treatments, announced the appointment of Christian Schade as president and chief executive. 1 October 2024
AstronauTx, a biotech developing novel treatments for Alzheimer's disease and other neurodegenerative disorders, has announced the appointment of Jane Rhodes as chief executive officer. 1 October 2024
USA-based engineered regulatory T cells (Tregs) company GentiBio today announced the appointment of Dr Mark Bach as chief medical officer. 30 September 2024
Recently-created by US biotech incubator Flagship Pioneering, Abiologics has announced the appointment of Maria-Chiara Magnone as its chief scientific officer. 26 September 2024
German privately-held biotech ARTCLINE Bio-Therapies today announced the appointment of Dirk Hessel as additional managing director of the company. 23 September 2024
Stalicla, a privately-held Swiss biotech, today announced that Dr Paulo Fontoura will be joining its drug development team as chief scientific and clinical development advisor. 19 September 2024
US contract development and manufacturing organization (CDMO) BioCentriq has appointed Syed Husain as its new chief executive (CEO), and as a member of the board of directors. 19 September 2024
Californian biopharma 89bio, a company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, has announced an important appointment. 17 September 2024
British biotech IMU Biosciences has announced key changes to its leadership team as it looks to grow in the field of precision medicine. 17 September 2024
Ohio, USA-based Trailhead Biosystems has appointed Josh Snow as its new chief commercial officer, as the company moves to expand its presence in the commercial market with its iPSC-derived human cell products. 16 September 2024
US neurological diseases specialist Ovid Therapeutics has announced the promotion of Meg Alexander to president and chief operating officer (COO). 12 September 2024
French cancer focused biotech Transgene has appointed two seasoned leaders in oncology who will be instrumental in advancing the company’s innovative immunotherapy programs 10 September 2024
Italy-based biotech AAVantgarde Bio has appointed Jayashree Sahni as its new chief medical officer, replacing Naveed Shams, who has held the role since 2022. 10 September 2024